Medical Cannabis Coin
Medical Cannabis Coin
Token: MCan


Medical Cannabis for the Blockchain Era Medical revolution for Well-being of Humanity Be a part of Medical Revolution break-through with Innovation Driven Medical Technology using Cannabis for Treatment of Cancer, Multiple Sclerosis, Epilepsy, HIV/A

PreICO dates
Start date: 2018-05-21
End date: 2018-08-30

ICO dates
Start date: 2018-08-31
End date: 2019-03-18

Registrated in: British Virgin Islands

Platform: Separate blockchain

PREMIUM ICO

Medical Cannabis Coin categories
Health
Medical Cannabis Coin whitepaper
Medical Cannabis Coin token sale
KYC passing required Yes | Whitelist No | Restriction for countries Cuba,Korea,Sudan,Syrian Arab Republic,USA
Soft cap €500,000,000
Hard cap €3,000,000,000
Tokens for sale 2750000000
Token distribution in ICO
60%
60%
Price 0.48 EUR
Price in PreICO 0.10 EUR
Minimal investment 50 EUR
Acceppting BCH,BTC,ETH,XRP

Medical Cannabis for the Blockchain Era

Medical revolution for Well-being of Humanity

Be a part of Medical Revolution break-through with Innovation Driven Medical Technology using Cannabis for Treatment of Cancer, Multiple Sclerosis, Epilepsy, HIV/AIDS, Post-Traumatic Stress Disorder and many more chronic diseases.

MCan coins will be listed on LATOKEN exchange at 18.03.2019!!!

Medican ltd (BVI company number 1463187) is incorporated in the British Virgin Islands as a BVI business company on the 6th day of February 2008.

With an excellent team of scientists, unique cannabis species, advanced technologies, a robust scientific community, and as part of an R&D and distribution center, we expand our knowledge of cannabis in tandem with setting high research standards that shall aid our research efforts.

The Company Medican Ltd has got approval with few exchanges to list the coin in their platforms. First will be LAtoken and will be followed with few others.

The Company offers Revenue Sharing to MCan’s coin Holders on a Monthly Basis.

The Company offers Dividend to MCan coin Holders on a quarterly basis.

 

Monthly Revenue Sharing

All MCAN coin holders registered at our system at the end of the date of every month (Time: 23:59) will automatically receive additional MCAN coin/s into their wallets as Monthly Bonus.

 

Quarterly Dividend sharing

All MCAN coin holders registered at our system at the end of the date of every Quarter (end of March, end of June, end of September, and end of December) (Time: 23:59). will automatically receive additional MCAN coin/s into their wallets as Quarterly Bonus

 

Extra Special New Year Bonus

We also come for 3rd exclusive new Year Bonus for those hold MCAN Coins. All MCAN Coins holders who registered holding at the year end 31 December time (23:59), this special Bonus only valid for MCAN Coins holders who hold 100,000 MCAN Coins in one wallet and Medican Ltd will give them an Extra Special Bonus of 10,000 MCAN Coins.


Medical Cannabis Coin news, social
Medical Cannabis Coin search trends in Google
Random whitepaper excerpts

MCAN WHITEPAPER
CONTENT
Disclaimer
Executive Summary
MCAN Background
Mission
Cultivation
Operation Plan
Harvesting
Green House and Cultivation Design
Requirements
Project scope
Current Market
Market Overview
Medicinal Properties of Cannabis
Eight Major Cannabinoids
Current Research
Pricing of Cannabis
Future of Cannabis
Process to Extract Cannabis Oil
MCAN - Products from Cannabis
Financial Projections
ICO
Coin Technology and Blockchain Uses
ICO Key Dates
Fund Allocation
How to buy MCAN Coin
MCAN
page
4
6
6
6
7
8
9
10
11
11
11
12
13
13
15
16
16
17
18
20
21
22
23
25
25
2
...

MCAN WHITEPAPER
Disclaimer
a. The purpose of this Whitepaper is to present Medican Ltd and
the Company’s Crypto C
oin
namely MCAN Coin to potential Coin holders in connection with the proposed Coin sale
and Initial Coin Offering (ICO).
b. The information set forth below may not be exhaustive and does not imply any elements
of a contractual relationship.
c. Its sole purpose is to provide relevant and reasonable information to potential Coin
Investors/holders in order for them to determine whether to undertake to purchase MCAN
Coins.
d. Nothing in this Whitepaper shall be deemed to constitute a prospectus of any sort or a
solicitation for investment, nor does it in any way pertain to an offer or a solicitation of an
offer to buy any securities in any jurisdiction.
e. This document is not composed in accordance with and is not subject to, laws or regulations
of any jurisdiction, which are designed to protect investors.
f. MCAN Coin is a utility Coin. This product ...

MCAN WHITEPAPER
“probable”, “project”, “should”, “would”, “will” or other similar terms. However, these
terms are not the exclusive means of identifying forward-looking statements. All
statements regarding MCAN
Platform’s financial position, business strategies, plans and
prospects and the future prospects of the industry which MCAN Platform is in are forward-
looking statements. These forward-looking statements, including but not limited to
statements as to MCAN Platform on prospects, future plans, other expected industry trends
and other matters discussed in this Whitepaper regarding MCAN Platform are matters that
are not historical facts, but only predictions.
j. Whitepaper can be modified to provide more detailed information. This English language
Whitepaper is the primary official source of information about the MCAN Coin.
MCAN
5
...

MCAN WHITEPAPER
EXECUTIVE SUMMARY:
Cannabi
s production has evolved to be the fastest growing industry in today’s world. Possessing
powerful properties to cure various chronic diseases, the medical cannabis industry attributes to
52% of the total cannabis market. This industry will grow to a $140 billion industry by 2027.
The research has proven futile to find a proper cure for chronic diseases. There is no other plant
that contains medically active properties as Cannabis. The problem arises due to the fact that there
are legal restrictions that belittle the growth of the Cannabis-based therapeutics. The medical
Cannabis can be taken in many forms - from inhalation to edibles and tinctures, cannabinoid-rich-
lotions, serums, oils, pills, and capsules. Testing and quality controls are an important aspect of
the research of medical Cannabis.
The objective is to apply for licenses to produce medical Cannabis and use the portion of funds for
support of medical research in this filed. A jaw-dro...

MCAN WHITEPAPER
Medican Ltd was established in British Virgin Island (BVI) under company number 1463187 on
6
th
day of February 2008. The purpose is to coordinate rigorous scientific studies to assess the
safety of Medical Cannabis and marketing the products.
The Company consists of an excellent team, advanced knowhow on technologies and a robust
scientific community. The Company aims to expand the knowledge of Cannabis to reach high
standards of research methods.
CULTIVATION
The Medical Cannabis market was worth $8.28 billion in 2017 and is expected to grow to $140
billion by 2027. Medical Cannabis is used in the treatment of oncological, neurological and
autoimmune conditions. The Medical Cannabis can also be prescribed in the following terms:
- To relieve symptoms of Multiple Sclerosis and muscle spasms.
- To relieve nausea caused by treatment with chemotherapy and Radiotherapy.
- Treatment for Refractory Epilepsy
- To stimulate appetite in patients with HIV.
...

MCAN WHITEPAPER
The research will help gain new theoretical knowledge and translate experiments to clinical
practices. The Company aims to present results at national and international meetings of medical
societies that use Medical Cannabis.
Operational Plan - Investment of funds
Creating cost-efficient cultivation is a must for businesses to thrive. The requirements
are as follows:
- 20 hectares of farmland and 40,000 square meters of indoor space.
- A minimum of 150 laborers.
- Competent staffs with appropriate skills.
- Personnel Training
- Personal Hygiene
- Security
- Buildings and facilities
- Production and maintenance
- Seeds and labeling material
The cultivation happens in three methods - Outdoor, greenhouse and indoor.
The harvest season for outdoor cultivators is once a year in the fall.
MCAN
8
...

MCAN WHITEPAPER
The indoor cultivators can produce year-round generating between 4 and 6 harvests per
year.
Greenhouse cultivators are a combination of exploiting natural light and leveraging
infrastructure and technology. The harvest can be between 1-4 times a year.
The company will be well equipped with greenhouses that can run year-round. Good
cultivation practices will be applied in the cultivation of Cannabis.
Harvesting
The conditions maintained will be wet soil or extremely high air humidity.

Ventilation is essential in the production, transport, and storage.
Primary Processing
Primary processing includes washing, cutting before drying, decontamination, freezing,
distillation, drying, etc.
MCAN
9
...

MCAN WHITEPAPER
The Establishment plans on building 2000 greenhouses of 3600 sq ft each.
These combine the latest technology in HVAC, light deprivation, environmental controls,
irrigation, insect exclusion, benching systems and hybrid techniques.
REQUIREMENTS:
- The biggest advantage is the abundance of natural light coming into the greenhouse.
- CO2 is essential for maximizing the quality and production of Cannabis.
- The Cannabis needs long daylight during the vegetative period and a good blackout for the
flowering production.
- Heating and cooling systems are important.
PROJECT SCOPE
The Establishment intends to infiltrate into the Medical Cannabis Cultivation market and set up
Institute of Medical Cannabis Research.
CURRENT MARKET
A new market research study published by Ameri Research estimates the global Cannabis market
to be worth $63.5 billion by 2024. Previously valued at $14.3 billion, the global market is expected
to grow at an annual growth rate of 21.1 % bet...

Medical Cannabis Coin Roadmap

1
1st Half, 2018
• Project Conceptualization Started • Corporation with various blockchain specialist, advisors to form strategic alliance • Form Strategic Alliance with other Medical Cannabis Research and Cultivation companies
2
2nd Half, 2018
• ICO - Pre-Sale & Institutional Sale • Pre- ICO 10% & ICO 50% of the coins will be distributed to expand EIMCR • Form strategic alliance with R&D departments in Universities in the area • Finalise discussions with Governmental figures
3
1st Half, 2019
• Strategic Alliance with companies to produce MCan Products • Establishment of pharmaceutical manufacturing facilities • Production of MCan cultivation Begins
4
2nd Half, 2019
• Adding more and the very best Consultants, Doctors and Scientists. • Medical Cannabis harvest • All Production of MCan Products Begins
5
2020
• Aggressive expansion to 13 new countries • Expansion to new verticals, concrete plans set and teams ready to expand to 13 countries in 2 years.
6
2021
• IPO (Initial Public Offering in major Global Exchanges) • NASDAQ, London Stock Exchange (LSE). • Further expansion & Global dominance • Aggressive marketing in current markets to 8 more new countries in 2 years. • Expansion of Manufacturing Facilities in few countries.
Chandra Sekar
Team member Chandra Sekar Chairman

Janusz Andrzej Skopowski
Team member Janusz Andrzej Skopowski C.E.O

Robert Jankowski
Team member Robert Jankowski C.O.O

Arkadiusz Frukacz
Team member Arkadiusz Frukacz C.F.O

Chandra Sekar
Chandra Sekar
Chairman
Chairman